Well, since the Crestor patent expired a couple of years ago and multiple generic rosuvastatins are now approved and available, the only thing that Astrazeneca may be selling is the rights to the name Crestor. In my opinion, no impact for Resverlogix. Rosuvastatin is rosuvastatin. If a combo pill is ever manufactured or marketed, then I would anticipate a generic rosuvastatin being used.
BearDownAZÂ
